longbridge
  • Explore
    Products
    Private Wealth ManagementUS StocksSG StocksHK StocksUS OptionsUS Pre-Market OptionsETFsREITsWarrantsCash Plus
    Tools
    Longbridge SkillLongbridge AILongbridge APIPaper TradingDividend HubLongbridge Pro
  • Café
longbridge

LEADS BIOLABS-B

09887

30.6800.00% ( 0.000 )
Delay
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile

News

  • Leads Biolabs falls 6% in Hong Kong trading

    Market Movers·Nov 18, 2026 at 02:41 AM
    098870.00%
  • Trustee Buys 220,700 H Shares Under Award Scheme

    Tip Ranks·Nov 17, 2026 at 04:38 AM
    098870.00%
  • Leads Biolabs hits record low

    Market Movers·Nov 17, 2026 at 01:32 AM
    098870.00%
  • Weekly Recap | LEADS BIOLABS-B -6.79%, most brokers rate it buy

    Weekly Review·Nov 14, 2026 at 05:48 AM
    098870.00%
  • Weekly Recap | LEADS BIOLABS-B +3.8%, most brokers rate it buy

    Weekly Review·Nov 7, 2026 at 09:37 AM
    098870.00%
  • Leads Biolabs climbs 6%

    Market Movers·Nov 5, 2026 at 02:23 AM
    098870.00%
  • Leads Biolabs Doses First Patient with Systemic Lupus Erythematosus in Phase I Part B Trial of LBL-047, a First-in-Class BDCA2/TACI Bifunctional Fusion Protein

    MorningStar·Oct 30, 2026 at 06:18 AM
    098870.00%
  • CLSA: Recent Pullback in China Healthcare Sector a Buying Opportunity as Overseas and Domestic Trends Improve

    AASTOCKS News·Oct 28, 2026 at 06:33 AM
    010930.00%018010.00%
  • Nanjing Leads Biolabs Reports 8.7-Month Median Survival With LBL-024 in Late-Line EP-NEC Trial

    PUBT·Oct 26, 2026 at 09:51 AM
    098870.00%
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy